Published in

American Association of Immunologists, The Journal of Immunology, 11(206), p. 2682-2691, 2021

DOI: 10.4049/jimmunol.1901337

American Association of Immunologists, The Journal of Immunology, 1_Supplement(208), p. 52.11-52.11, 2022

DOI: 10.4049/jimmunol.208.supp.52.11

Links

Tools

Export citation

Search in Google Scholar

UBX Domain Protein 6 Positively Regulates JAK-STAT1/2 Signaling

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Type I/III IFNs induce expression of hundreds of IFN-stimulated genes through the JAK/STAT pathway to combat viral infections. Although JAK/STAT signaling is seemingly straightforward, it is nevertheless subjected to complex cellular regulation. In this study, we show that an ubiquitination regulatory X (UBX) domain-containing protein, UBXN6, positively regulates JAK-STAT1/2 signaling. Overexpression of UBXN6 enhanced type I/III IFNs–induced expression of IFN-stimulated genes, whereas deletion of UBXN6 inhibited their expression. RNA viral replication was increased in human UBXN6-deficient cells, accompanied by a reduction in both type I/III IFN expression, when compared with UBXN6-sufficient cells. Mechanistically, UBXN6 interacted with tyrosine kinase 2 (TYK2) and inhibited IFN-β–induced degradation of both TYK2 and type I IFNAR. These results suggest that UBXN6 maintains normal JAK-STAT1/2 signaling by stabilizing key signaling components during viral infection. Supported by R01AI132526 and R21AI155820 to Penghua Wang